Cameron Smith

Person

San Bruno, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 11,878,977
- Issue date Jan 23, 2024
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,718,616
- Issue date Aug 8, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 11,667,637
- Issue date Jun 6, 2023
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 11,453,668
- Issue date Sep 27, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 11,299,492
- Issue date Apr 12, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 11,254,669
- Issue date Feb 22, 2022
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,954,237
- Issue date Mar 23, 2021
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,550,118
- Issue date Feb 4, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,526,330
- Issue date Jan 7, 2020
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 10,519,153
- Issue date Dec 31, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,392,386
- Issue date Aug 27, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused imidazo-piperidine JAK inhibitors
- Patent number 10,208,040
- Issue date Feb 19, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
JAK inhibitors containing a 4-membered heterocyclic amide
- Patent number 10,196,393
- Issue date Feb 5, 2019
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK kinase inhibitor compounds for treatment of respiratory disease
- Patent number 10,100,049
- Issue date Oct 16, 2018
- Theravance Biopharma R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,873,696
- Issue date Jan 23, 2018
- Theravance Biopharma R&D IP, LLC
- Cameron Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,725,448
- Issue date Aug 8, 2017
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,555,041
- Issue date Jan 31, 2017
- Theravance Biopharma R&D IP, LLC
- Cameron Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,487,514
- Issue date Nov 8, 2016
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 9,216,971
- Issue date Dec 22, 2015
- Theravance Biopharma R&D IP, LLC
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 9,120,758
- Issue date Sep 1, 2015
- Theravance Biopharma R&D IP, LLC
- Cameron Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 8,846,913
- Issue date Sep 30, 2014
- Theravance Biopharma R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 8,815,907
- Issue date Aug 26, 2014
- Theravance Biopharma R&D IP, LLC
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 8,563,512
- Issue date Oct 22, 2013
- Theravance, Inc.
- Cameron Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 8,492,407
- Issue date Jul 23, 2013
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amidine-containing compounds useful as muscarinic receptor antagonists
- Patent number 8,450,362
- Issue date May 28, 2013
- Theravance, Inc.
- YuHua Ji
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Neprilysin inhibitors
- Patent number 8,449,890
- Issue date May 28, 2013
- Theravance, Inc.
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Patent number 8,202,891
- Issue date Jun 19, 2012
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS
- Publication number 20240092758
- Publication date Mar 21, 2024
- THERAVANCE BIOPHARMA R&D IP, LLC
- Robert Murray MCKINNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20230063643
- Publication date Mar 2, 2023
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20220306624
- Publication date Sep 29, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20220289737
- Publication date Sep 15, 2022
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20210269436
- Publication date Sep 2, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE
- Publication number 20210130351
- Publication date May 6, 2021
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20200216447
- Publication date Jul 9, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20200181141
- Publication date Jun 11, 2020
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20190337945
- Publication date Nov 7, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20190127371
- Publication date May 2, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20190119275
- Publication date Apr 25, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20190106420
- Publication date Apr 11, 2019
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS
- Publication number 20180258088
- Publication date Sep 13, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE
- Publication number 20180258087
- Publication date Sep 13, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- PAUL R. FATHEREE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20180051023
- Publication date Feb 22, 2018
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20170217959
- Publication date Aug 3, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Cameron Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
- Publication number 20170121327
- Publication date May 4, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Paul R. Fatheree
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20170066764
- Publication date Mar 9, 2017
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20160184316
- Publication date Jun 30, 2016
- THERAVANCE BIOPHARMA R&D IP, LLC
- Cameron Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20150133658
- Publication date May 14, 2015
- THERAVANCE BIOPHARMA R&D IP, LLC
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...
- Publication number 20140329857
- Publication date Nov 6, 2014
- THERAVANCE BIOPHARMA R&D IP, LLC
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20140011997
- Publication date Jan 9, 2014
- Theravance, Inc.
- Cameron Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...
- Publication number 20130281489
- Publication date Oct 24, 2013
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20130245260
- Publication date Sep 19, 2013
- Theravance, Inc.
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS
- Publication number 20120277250
- Publication date Nov 1, 2012
- Theravance, Inc.
- YuHua Ji
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...
- Publication number 20120232053
- Publication date Sep 13, 2012
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20120213807
- Publication date Aug 23, 2012
- Theravance, Inc.
- Melissa Fleury
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEPRILYSIN INHIBITORS
- Publication number 20120157386
- Publication date Jun 21, 2012
- Theravance, Inc.
- Cameron SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS
- Publication number 20090170870
- Publication date Jul 2, 2009
- YuHua Ji
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quaternary ammonium compounds useful as muscarinic receptor antagon...
- Publication number 20080269190
- Publication date Oct 30, 2008
- Theravance, Inc.
- Craig Husfeld
- C07 - ORGANIC CHEMISTRY

Cameron Smith

Person

Patents Grantslast 30 patents

JAK inhibitors containing a 4-membered heterocyclic amide

JAK kinase inhibitor compounds for treatment of respiratory disease

Fused imidazo-piperidine JAK inhibitors

JAK inhibitors containing a 4-membered heterocyclic amide

JAK kinase inhibitor compounds for treatment of respiratory disease

Fused imidazo-piperidine JAK inhibitors

JAK inhibitors containing a 4-membered heterocyclic amide

JAK inhibitors containing a 4-membered heterocyclic amide

JAK kinase inhibitor compounds for treatment of respiratory disease

Fused imidazo-piperidine JAK inhibitors

JAK inhibitors containing a 4-membered heterocyclic amide

Fused imidazo-piperidine JAK inhibitors

JAK inhibitors containing a 4-membered heterocyclic amide

JAK kinase inhibitor compounds for treatment of respiratory disease

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Neprilysin inhibitors

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Neprilysin inhibitors

Neprilysin inhibitors

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Neprilysin inhibitors

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Amidine-containing compounds useful as muscarinic receptor antagonists

Neprilysin inhibitors

Quaternary ammonium compounds useful as muscarinic receptor antagon...

Patents Applicationslast 30 patents

IMIDAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

JAK KINASE INHIBITOR COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASE

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS

JAK INHIBITORS CONTAINING A 4-MEMBERED HETEROCYCLIC AMIDE

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...

NEPRILYSIN INHIBITORS

QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...

NEPRILYSIN INHIBITORS

AMIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS

QUATERNARY AMMONIUM COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGON...

NEPRILYSIN INHIBITORS

NEPRILYSIN INHIBITORS

AMIDINE-CONTAINING COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS

Quaternary ammonium compounds useful as muscarinic receptor antagon...